December 18, 2025
Shardul Amarchand Mangaldas & Co. (SAM) advised Nephrocare Health Services Limited (“Nephroplus”) on its initial public…
December 17, 2025
Shardul Amarchand Mangaldas & Co. (SAM) advised Attentive.ai group on their Series B fundraising round totaling…
December 16, 2025
Shardul Amarchand Mangaldas & Co. (SAM) advised Tata Steel Limited (“TSL”) with respect to its acquisition…
December 16, 2025
Shardul Amarchand Mangaldas & Co. (SAM) advised Main Capital Partners and its portfolio company, BizzDesign, on…
The Bar Council of India does not permit solicitation of work and advertising by legal practitioners and advocates. By accessing the Shardul Amarchand Mangaldas & Co. website (our website), the user acknowledges that:
Click here for important public notice from the Firm.